Cargando…

The Complex Relationship between Diabetic Retinopathy and High-Mobility Group Box: A Review of Molecular Pathways and Therapeutic Strategies

High-mobility group box 1 (HMGB1) is a protein that is part of a larger family of non-histone nuclear proteins. HMGB1 is a ubiquitary protein with different isoforms, linked to numerous physiological and pathological pathways. HMGB1 is involved in cytokine and chemokine release, leukocyte activation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nebbioso, Marcella, Lambiase, Alessandro, Armentano, Marta, Tucciarone, Giosuè, Bonfiglio, Vincenza, Plateroti, Rocco, Alisi, Ludovico
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464385/ https://www.ncbi.nlm.nih.gov/pubmed/32722545 http://dx.doi.org/10.3390/antiox9080666

Ejemplares similares

Eye drop emulsion containing 0.1% cyclosporin (1 mg/mL) for the treatment of severe vernal keratoconjunctivitis: an evidence-based review and place in therapy
por: Nebbioso, Marcella, et al.
Publicado: (2019)

Insights into Novel Choroidal and Retinal Clinical Signs in Neurofibromatosis Type 1
por: Mallone, Fabiana, et al.
Publicado: (2023)

Analysis of the Pathogenic Factors and Management of Dry Eye in Ocular Surface Disorders
por: Nebbioso, Marcella, et al.
Publicado: (2017)

Ten-Year Outcomes of Intravitreal Bevacizumab for Myopic Choroidal Neovascularization: Analysis of Prognostic Factors
por: Mallone, Fabiana, et al.
Publicado: (2021)

Electrophysiological Study of Visual Pathways in Nevoid Basal Cell Carcinoma Syndrome Patients
por: Moramarco, Antonietta, et al.
Publicado: (2021)

Neurofibromatosis Type 1: Ocular Electrophysiological and Perimetric Anomalies
por: Nebbioso, Marcella, et al.
Publicado: (2020)

Oxidative Stress Implication in Retinal Diseases—A Review
por: Nebbioso, Marcella, et al.
Publicado: (2022)

Comment on “Keratoprosthesis in dry eye disease”
por: Iannetti, Ludovico, et al.
Publicado: (2023)

Evidence of Pepsin-Related Ocular Surface Damage and Dry Eye (PROD Syndrome) in Patients with Laryngopharyngeal Reflux
por: Plateroti, Rocco, et al.
Publicado: (2020)

Recent Advances and Disputes About Curcumin in Retinal Diseases
por: Nebbioso, Marcella, et al.
Publicado: (2021)

Understanding Drivers of Ocular Fibrosis: Current and Future Therapeutic Perspectives
por: Mallone, Fabiana, et al.
Publicado: (2021)

Correlation between Morphological Characteristics of Macular Edema and Visual Acuity in Young Patients with Idiopathic Intermediate Uveitis
por: Iannetti, Ludovico, et al.
Publicado: (2023)

High-mobility group box-1 and biomarkers of inflammation in the vitreous from patients with proliferative diabetic retinopathy
por: El-Asrar, Ahmed M. Abu, et al.
Publicado: (2011)

Therapeutic Approaches with Intravitreal Injections in Geographic Atrophy Secondary to Age-Related Macular Degeneration: Current Drugs and Potential Molecules
por: Nebbioso, Marcella, et al.
Publicado: (2019)

Bilateral Angle Recession and Chronic Post-Traumatic Glaucoma: A Review of the Literature and a Case Report
por: Iannucci, Valeria, et al.
Publicado: (2023)

High-Mobility Group Box-1 and Endothelial Cell Angiogenic Markers in the Vitreous from Patients with Proliferative Diabetic Retinopathy
por: Abu El-Asrar, Ahmed M., et al.
Publicado: (2012)

A cross‐sectional study of vitreous and serum high mobility group box‐1 levels in proliferative diabetic retinopathy
por: Shen, Yinchen, et al.
Publicado: (2019)

Tear Ferning Test and Pathological Effects on Ocular Surface before and after Topical Cyclosporine in Vernal Keratoconjunctivitis Patients
por: Nebbioso, Marcella, et al.
Publicado: (2018)

OCT biomarkers as predictors of visual improvement in diabetic macular edema eyes receiving dexamethasone implants
por: Visioli, Giacomo, et al.
Publicado: (2023)

An Update on the Ophthalmologic Features in the Phakomatoses
por: Abdolrahimzadeh, Solmaz, et al.
Publicado: (2016)

High-mobility group box 1: role in ARDS
por: Ishizaka, A, et al.
Publicado: (2005)

High‐Mobility Group Box‐1 and Liver Disease
por: Gaskell, Harriet, et al.
Publicado: (2018)

High mobility group box 1 in diabetic nephropathy
por: Shi, Haitao, et al.
Publicado: (2017)

High Mobility Group Box 1 in Human Cancer
por: Rapoport, Bernardo L., et al.
Publicado: (2020)

The dual role and therapeutic potential of high-mobility group box 1 in cancer
por: He, Si-Jia, et al.
Publicado: (2017)

X-linked dominant RPGR gene mutation in a familial Coats angiomatosis
por: Nebbioso, Marcella, et al.
Publicado: (2021)

Pivotal neuroinflammatory and therapeutic role of high mobility group box 1 in ischemic stroke
por: Richard, Seidu A., et al.
Publicado: (2017)

High mobility group box-1: a potential therapeutic target for allergic rhinitis
por: Wu, Shuhua, et al.
Publicado: (2023)

High mobility group box 1: as a 'testament' mediator
por: Maruyama, I, et al.
Publicado: (2005)

The Role of High Mobility Group Box 1 in Innate Immunity
por: Lee, Shin-Ae, et al.
Publicado: (2014)

High Mobility Group Box Protein-1 in Wound Repair
por: Ranzato, Elia, et al.
Publicado: (2012)

High-Mobility Group Box 1 in Dry Eye Inflammation
por: Lema, Carolina, et al.
Publicado: (2018)

The Role of High Mobility Group Box 1 in Ischemic Stroke
por: Ye, Yingze, et al.
Publicado: (2019)

Role of High-Mobility Group Box-1 in Liver Pathogenesis
por: Khambu, Bilon, et al.
Publicado: (2019)

High Mobility Group Box 1 Protein in Cerebral Thromboemboli
por: Essig, Fabian, et al.
Publicado: (2021)

Urinary and serum levels of high mobility group box 1
por: Nakamura, Toshihiko, et al.
Publicado: (2023)

High mobility group box 1 contributes to wound healing induced by inhibition of dipeptidylpeptidase 4 in cultured keratinocytes
por: Sinagra, Tiziana, et al.
Publicado: (2015)

Role of Extracellular High-Mobility Group Box-1 as a Therapeutic Target of Gastric Cancer
por: Takaki, Wataru, et al.
Publicado: (2022)

Role of high mobility group box protein 1 in depression: A mechanistic and therapeutic perspective
por: Wang, Shu, et al.
Publicado: (2022)

Macular Ganglion Cell Layer Thickness after Macula-Off Rhegmatogenous Retinal Detachment Repair: Scleral Buckling versus Pars Plana Vitrectomy
por: Gharbiya, Magda, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_65e2180u96k7pmmll04n4uib2t